Michael Nicholson, DO

New episode of #TheHealthBeat! Introducing the PREVENT equation, a 10 and 30-year #cardiovascular risk calculator that leverages data from standard primary care physicals. Watch our episode on the new tool and its supporting guidelines on YouTube: youtube.com/watch?v=QJMprN…

Part 1 of a new 3-part series on BLVR is live on #Vumedi! Dr. Michael Nicholson outlines the clinical background and patient selection principles for bronchoscopic lung volume reduction. 🎥 tinyurl.com/2h4kjuet #BLVR #Pulmonology

How does #pulmonaryhypertension affect #lungtransplant waitlist outcomes in patients with chronic HP? See our work with @SRTRNews led by @TemplePCCM fellow @DrMikeNicks doi.org/10.1016/j.jhlt… @ISHLT @DhananiZehra @TempleLung

Thank you to @HealioPulm for phenomenal coverage! So much work still to be done in the field of Alpha-1 Antitrypsin Deficiency and BLVR. We are hard at work to continue this research and very excited for what’s to come! @atscommunity @TemplePCCM @TempleHealth

#ATS2024: After bronchoscopic lung volume reduction patients with #COPD and alpha-1 antitrypsin deficiency (#AATD) had better #lung function. @atscommunity @DrMikeNicks @TempleHealth Read more🔽 healio.com/news/pulmonolo…

⚡️Weekend read⚡️ Remember a 2023 review by Nicholson et al.: #Thoracentesis for the Diagnosis and Management of #PleuralEffusions: The Current State of a Centuries-Old Procedure 👉mdpi.com/2593200 #ultrasound

Monte Carlo simulations suggest navigation bronchoscopy-first approach to diagnosis of pulmonary nodules with radiologically normal mediastinum may result in more diagnostic bronchoscopies. Read the article from the July issue of @journal_CHEST: hubs.la/Q01gvBmy0 #MedEd

First-year @TemplePCCM fellows saving mannequin lives at the Temple Institute for Clinical Simulation!